Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inderal for reducing bleeding during abdominal hysterectomy
IRCT20240906062960N1Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial comparing Inderal with Placebo (2 arms). Primary endpoints: Hemoglobin level 6 hours after surgery and Hemoglobin level 12 hours after surgery. Started Oct 2024; status: completed.
02
Drugs
propranolol
Beyond the preview
Go deeper on IRCT20240906062960N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240906062960N1.